BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $218,324 | +0.2% | 4,792 | -10.8% | 0.05% | -9.4% |
| Q1 2023 | $217,969 | +79450.7% | 5,374 | 0.0% | 0.05% | -24.3% |
| Q4 2022 | $274 | -99.9% | 5,374 | 0.0% | 0.07% | -10.3% |
| Q3 2022 | $289,000 | -9.4% | 5,374 | +8.0% | 0.08% | -20.4% |
| Q2 2022 | $319,000 | -17.4% | 4,974 | 0.0% | 0.10% | +16.7% |
| Q1 2022 | $386,000 | -9.6% | 4,974 | 0.0% | 0.08% | -24.3% |
| Q4 2021 | $427,000 | +6.8% | 4,974 | 0.0% | 0.11% | +24.7% |
| Q3 2021 | $400,000 | 0.0% | 4,974 | 0.0% | 0.09% | +4.7% |
| Q2 2021 | $400,000 | -4.8% | 4,974 | 0.0% | 0.08% | -11.5% |
| Q1 2021 | $420,000 | +5.3% | 4,974 | 0.0% | 0.10% | +1.1% |
| Q4 2020 | $399,000 | -8.9% | 4,974 | -8.7% | 0.10% | -16.7% |
| Q3 2020 | $438,000 | -6.6% | 5,449 | 0.0% | 0.11% | -9.5% |
| Q2 2020 | $469,000 | +6.1% | 5,449 | 0.0% | 0.13% | -11.3% |
| Q1 2020 | $442,000 | +6.2% | 5,449 | +9.5% | 0.14% | +37.9% |
| Q4 2019 | $416,000 | -4.4% | 4,974 | 0.0% | 0.10% | -20.8% |
| Q3 2019 | $435,000 | +6.9% | 4,974 | 0.0% | 0.13% | +13.0% |
| Q2 2019 | $407,000 | +0.7% | 4,974 | 0.0% | 0.12% | +26.4% |
| Q1 2019 | $404,000 | -75.3% | 4,974 | -80.0% | 0.09% | -77.2% |
| Q4 2018 | $1,638,000 | -100.0% | 24,882 | -41.8% | 0.40% | -40.4% |
| Q3 2018 | $3,298,064,000 | +101347.7% | 42,782 | -2.8% | 0.67% | -2.3% |
| Q2 2018 | $3,251,000 | +10.3% | 44,032 | -2.8% | 0.69% | +7.5% |
| Q1 2018 | $2,947,000 | +815.2% | 45,312 | +811.0% | 0.64% | +914.3% |
| Q4 2017 | $322,000 | +3.2% | 4,974 | 0.0% | 0.06% | -1.6% |
| Q3 2017 | $312,000 | +3.7% | 4,974 | 0.0% | 0.06% | +3.2% |
| Q2 2017 | $301,000 | +16.7% | 4,974 | 0.0% | 0.06% | +10.7% |
| Q1 2017 | $258,000 | +10.7% | 4,974 | 0.0% | 0.06% | +9.8% |
| Q4 2016 | $233,000 | -1.7% | 4,974 | 0.0% | 0.05% | -3.8% |
| Q3 2016 | $237,000 | +5.3% | 4,974 | 0.0% | 0.05% | +3.9% |
| Q2 2016 | $225,000 | +10.3% | 4,974 | 0.0% | 0.05% | +10.9% |
| Q1 2016 | $204,000 | -41.4% | 4,974 | 0.0% | 0.05% | -41.0% |
| Q2 2015 | $348,000 | +2.1% | 4,974 | 0.0% | 0.08% | +5.4% |
| Q1 2015 | $341,000 | -6.6% | 4,974 | 0.0% | 0.07% | -3.9% |
| Q4 2014 | $365,000 | +2.2% | 4,974 | 0.0% | 0.08% | -1.3% |
| Q3 2014 | $357,000 | -0.8% | 4,974 | 0.0% | 0.08% | +1.3% |
| Q2 2014 | $360,000 | -1.6% | 4,974 | 0.0% | 0.08% | -2.5% |
| Q1 2014 | $366,000 | -2.1% | 4,974 | -7.4% | 0.08% | -3.7% |
| Q4 2013 | $374,000 | +5.9% | 5,374 | 0.0% | 0.08% | -1.2% |
| Q3 2013 | $353,000 | -5.1% | 5,374 | 0.0% | 0.08% | -5.7% |
| Q2 2013 | $372,000 | – | 5,374 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |